Fludeoxyglucose is under investigation in clinical trial NCT03262389 (Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.